Pfizer (PFE, Financial) experienced a 2.3% increase, reaching $29.85. The rise follows news that Pfizer's CEO plans to meet next week with key leaders from activist investor Starboard Value. Starboard Value currently holds approximately $1 billion in Pfizer stock and is advocating for changes to improve the company's performance.
In addition, Pfizer and its German partner BioNTech secured a legal victory in the London High Court, invalidating two patents held by competitor CureVac. The disputed technology underpins Pfizer and BioNTech's COVID-19 vaccine.